Literature DB >> 11402123

Rescue treatment with abciximab in acute ischemic stroke.

K Y Lee1, J H Heo, S I Lee, P H Yoon.   

Abstract

In acute ischemic stroke, reocclusion after an initially successful thrombolysis treatment can occur and is associated with increased morbidity and mortality. The authors present the successful use of abciximab, a platelet glycoprotein IIb/IIIa receptor inhibitor, in a patient with a thrombotic occlusion of the proximal middle cerebral artery, which was refractory to combined IV and intra-arterial thrombolysis and percutaneous intracranial balloon angioplasty.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11402123     DOI: 10.1212/wnl.56.11.1585

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

Review 1.  Glycoprotein IIb/IIIa antagonists in acute ischaemic stroke: current status and future directions.

Authors:  Pitchaiah Mandava; Perumal Thiagarajan; Thomas A Kent
Journal:  Drugs       Date:  2008       Impact factor: 9.546

2.  Abciximab for thrombolysis during intracranial aneurysm coiling.

Authors:  Jan Gralla; Adam T M Rennie; Rufus A Corkill; Shivendra T Lalloo; Andrew Molyneux; James V Byrne; Wilhem Kuker
Journal:  Neuroradiology       Date:  2008-09-20       Impact factor: 2.804

3.  Endovascular treatment of acute embolism of the major cerebral arteries. The value of balloon disruption of the embolus.

Authors:  S Ota; T Ota; K Goto; I Inoue; T Ota
Journal:  Interv Neuroradiol       Date:  2005-01-05       Impact factor: 1.610

4.  Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke.

Authors:  Kyung Yul Lee; Dong Ik Kim; Seo Hyun Kim; Seung Ik Lee; Hae Woong Chung; Yong Woon Shim; Seung Min Kim; Ji Hoe Heo
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

5.  A Pilot Trial of Low-Dose Intravenous Abciximab and Unfractionated Heparin for Acute Ischemic Stroke: Translating GP IIb/IIIa Receptor Inhibition to Clinical Practice.

Authors:  Pitchaiah Mandava; William Dalmeida; Jane A Anderson; Perumal Thiagarajan; Roderic H Fabian; Raymond U Weir; Thomas A Kent
Journal:  Transl Stroke Res       Date:  2010-09       Impact factor: 6.829

6.  Vertebrobasilar thrombolysis with intravenous tirofiban: case report.

Authors:  David S Liebeskind; John R Pollard; Eric D Schwartz; Brett L Cucchiara; Michael L McGarvey; Robert W Hurst
Journal:  J Thromb Thrombolysis       Date:  2002-04       Impact factor: 2.300

Review 7.  Acute stroke therapy 1981-2009.

Authors:  Bernd Eckert
Journal:  Klin Neuroradiol       Date:  2009-05-15

8.  Rescue treatment with intra-arterial tirofiban infusion and emergent carotid stenting.

Authors:  Tae Jin Song; Kee Oog Lee; Dong Joon Kim; Kyung-Yul Lee
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

9.  Rescue use of tirofiban for acute carotid in-stent thrombosis.

Authors:  Kwon Duk Seo; Kee Oog Lee; Dong Joon Kim; Kyung-Yul Lee
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

10.  Repeated thrombolytic therapy in patients with recurrent acute ischemic stroke.

Authors:  Han Soo Yoo; Young Dae Kim; Hye Sun Lee; Dongbeom Song; Tae Jin Song; Byung Moon Kim; Dong Joon Kim; Dong Ik Kim; Ji Hoe Heo; Hyo Suk Nam
Journal:  J Stroke       Date:  2013-09-27       Impact factor: 6.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.